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Background
Cystic Fibrosis (CF) occurs randomly in children across
all European social strata providing an opportunity to
sample their underpinning health care provision for this
rare disease in an unbiased manner. We developed a 35
country European cystic fibrosis (CF) demographic reg-
istry to compare CF outcomes through an FP6 pro-
gramme of the EU called EuroCareCF (http://www.
eurocarecf.eu).
Methods
We applied methods (http://www.cystic-fibrosis.org.uk)
previously used to create country-specific registries after
inviting participation through the European CF Society
and CF patient organisations using a double hub (Dun-
dee and Prague) and spoke model supplemented by con-
ferences, workshops and telephone support using a
single data collection system. Implementing this com-
mon data collection platform, we collated demographic
and genotype data in around 30,000 patients scattered
from Iceland to the Black Sea.
Results
Amongst the ~30,000 CF patients in our Registry, a
widely different country-specific prevalence of childhood
CF exists that cannot be explained by differences in
population size, underlying heterozygote CF gene fre-
quency or under-ascertainment. In particular, we do not
believe that the lattermost can explain our findings
because in late childhood, we observe a significant pau-
city of the clinically severe homozygous F508-del form
of CF that is of early childhood onset in 90% of cases
and is widely dispersed across mainland Europe.
Conclusions
It is likely that an excess premature CF mortality in
childhood still occurs across many parts of Europe, a
mortality that has largely disappeared in countries such
as the UK, France Germany and other wealthy nations.
We suggest that much of (better resourced) Western
Europe now has a vanishingly low mortality for the
severe commonly occurring F508del homozygous CF in
childhood that is not replicated in our study in many
European countries. The reasons require investigation.
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